Selzentry (Maraviroc, Celsentri)

The Latest

An Overview of Selzentry (Maraviroc, Celsentri)

Brand Name: Selzentry Other Name(s): MVC Drug Class: Entry Inhibitor

By AIDSinfo

Selzentry (Maraviroc) for HIV Prevention

This fact sheet covers the current status of investigations into the use of Selzentry as pre-exposure prophylaxis (PrEP).

By AIDSinfo

Maraviroc (Selzentry, Celsentri)

Table of Contents

What Is Maraviroc? Who Should Take It? What About Drug Resistance? How Is Maraviroc Taken? What Are the Side Effects? How Does It React With Other Drugs? The Bottom Line

What Is Maraviroc?

Maraviroc (Selzentry in the ...

By AIDS InfoNet

Selzentry

Brand name: Selzentry

Generic name: maraviroc, T-20, or MVC

Class: CCR5 antagonist (a type of entry inhibitor)

Manufacturer: ViiV Healthcare, www.viivhealthcare.com, (877) 844-8872

AWP: $1,199.84/month for 150 mg or 300 mg tablets

Standard Dose:...

By Positively Aware

Selzentry Labeling Includes New Warnings for People With Kidney Problems: A Blog Entry by Myles Helfand

The CCR5 inhibitor Selzentry (Celsentri, maraviroc) should be used with caution by HIV-positive people with kidney problems, according to a U.S. Food and Drug Administration release. The release provides details on several changes that have just been...

By Myles Helfand

FAQs About Selzentry (Maraviroc, Celsentri)

Don't see your question? Ask it in our Choosing Your Meds forum or Managing Side Effects of HIV Treatment forum!

Basics | Tropism Testing | Drug Resistance | Side Effects

Basics

Is Selzentry appropriate for someone just starting HIV medications or...

A Revolutionary New Way to Fight HIV/AIDS: CCR5 Inhibitors

From The Body

Introduction

//

var oliver = new SWFObject('/cmsWebLib/mediaplayer/mediaplayer.swf',"playerOliver","320","240","8"); oliver.addParam("allowfullscreen","true"); oliver.addVariable("width","320"); oliver.addVariable("height","240"); ol...

A New Way to Fight HIV: CCR5 Inhibitors

The past year has brought so many new drug approvals that even some HIV experts are scratching their heads as they try to figure out how all of these meds work and how they can best be used to treat people with HIV.

Today, we're going to look at one...

By Bonnie Goldman

The Basics on Maraviroc: An Interview With Joel Gallant, M.D., M.P.H.

It's been a year since the United States approved a new HIV medication, and four long years since we witnessed the birth of a whole new class of meds. But on Aug. 6, 2007, the U.S. Food and Drug Administration [FDA] gave the green light to maraviro...

By Myles Helfand